Dr. Darla Kaye Liles, MD

Dr. Liles practices at ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina.

Dr. Liles' NPI, 1528051729, was assigned on August 24, 2005. Dr. Liles graduated from UMKC School of Medicine in 1986. Dr. Liles' North Carolina license number on file is 39014.

Dr. Liles' primary practice is ECU Health Medical Center, at 2100 Stantonsburg Rd, Greenville, NC 27834 in Pitt County. The practice phone is (252) 847-4100.

Dr. Liles' primary practice is ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina. Dr. Liles is also affiliated with Outer Banks Health Hospital. The medical group on file is ECU Health. Dmand AI also links Dr. Liles to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Liles practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Liles' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Liles is board certified in hematology by the American Board of Internal Medicine. Dr. Liles has a license on file in North Carolina.

Dmand AI lists chronic anemia, chronic leukemia, immune deficiency disease, lymphoma, multiple myeloma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Liles treats.

CMS data shows 846 Medicare services from Dr. Liles across 8 procedure codes in 2024, for 333 Medicare patients. Medicare paid $59,250 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 333 Medicare patients who saw Dr. Liles in 2024. The largest group is 65 to 74, with 132 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Liles' median patient age at 71, with 56% women.

In 2024, Dr. Liles wrote 2,469 Medicare Part D claims for 235 patients. 69% of them were for generic drugs. CMS names the drug for 2,136 of them, across 52 drugs with 11 or more claims each, at $7,119,357 in total drug cost. In 2023, CMS named 1,785 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Liles for performance year 2024, reported through an alternative payment model (APM). Dr. Liles accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 54 papers to Dr. Liles, published from 2010 to 2025. 2024 was the busiest year, with 9. The most frequent topics are Anemia, Sickle Cell, Antibodies, Monoclonal, Humanized and Antineoplastic Combined Chemotherapy Protocols. Dr. Liles has published most often in Blood Adv. Dr. Liles' most frequent co-authors are Charles L. Knupp, MD, Nirmish R. Shah, MD and Victor R. Gordeuk, MD.

Dmand AI links Dr. Liles to 20 clinical trials, 8 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Anemia, Sickle Cell, Anemia, Hemolytic, Congenital and Leukemia, Lymphocytic, Chronic, B-Cell. National Cancer Institute (NCI) sponsors the most, 7.

CMS Open Payments shows 107 general payments to Dr. Liles from 34 drug and device companies from 2016 to 2025. Accredited education speaker fees make up the largest share, 84% of the total. Pfizer Inc. paid the most, $59,981. It also lists 20 research payments totaling $38,099 from 2017 to 2023.

Dmand AI lists 1 award for Dr. Liles, most recently Regional Top Doctor in 2014.

Dr. Liles graduated from UMKC School of Medicine in 1986. Dr. Liles is a member of ASH.

Dr. Liles is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.